WaveMan · Form 4
ADAR1 Capital Management, LLC insider trades
> Search tickers & screens ⌘K
LIVE

ADAR1 Capital Management, LLC insider trades

ADAR1 Capital Management, LLC has filed 13 Form 4s with the SEC that we hold, for InMed Pharmaceuticals Inc. (INM) (10% owner), Tenax Therapeutics, INC. (TENX) (10% owner), NextCure, Inc. (NXTC) (10% owner) and Rallybio Corp (RLYB) (10% owner), among 6 companies in all. Across all of them we count 39 purchases worth $7.6M and 0 sales worth $0 reported on Form 4. In the last 12 months: 36 purchases ($7.5M) and 0 sales ($0). The largest single trade was a purchase of 900,000 shares of Tenax Therapeutics, INC. worth $1.6M, dated 2026-09-03. The first filing on our record is dated 2024-08-12 and the latest 2026-10-08.

InMed Pharmaceuticals Inc. (INM)

10% owner · 4 filings · 10 purchases and sales
Trade dateCodeSharesValue as filedFiled
2026-07-15P, purchase reported on Form 41,000$1.6K2026-07-17
2026-09-14P, purchase reported on Form 428,505$36.9K2026-09-16
2026-09-15P, purchase reported on Form 454,256$70.4K2026-09-16
2026-09-16P, purchase reported on Form 48,340$10.8K2026-09-16
2026-10-01P, purchase reported on Form 416,431$21.8K2026-10-05
2026-10-02P, purchase reported on Form 48,307$11.0K2026-10-05
2026-10-05P, purchase reported on Form 418,182$24.2K2026-10-05
2026-10-06P, purchase reported on Form 45,601$7.4K2026-10-08
2026-10-07P, purchase reported on Form 43,046$4.1K2026-10-08
2026-10-08P, purchase reported on Form 42,256$3.0K2026-10-08

Tenax Therapeutics, INC. (TENX)

10% owner · 3 filings · 7 purchases and sales
Trade dateCodeSharesValue as filedFiled
2026-08-20P, purchase reported on Form 4202,124$359.5K2026-08-24
2026-08-21P, purchase reported on Form 4716,369$1.3M2026-08-24
2026-08-24P, purchase reported on Form 4107,374$188.4K2026-08-24
2026-08-31P, purchase reported on Form 4403,571$722.6K2026-09-02
2026-09-01P, purchase reported on Form 4179,058$321.6K2026-09-02
2026-09-02P, purchase reported on Form 4187,704$337.6K2026-09-02
2026-09-03P, purchase reported on Form 4900,000$1.6M2026-09-08

NextCure, Inc. (NXTC)

10% owner · 2 filings · 12 purchases and sales
Trade dateCodeSharesValue as filedFiled
2026-07-27P, purchase reported on Form 47,798$39.0K2026-07-29
2026-07-28P, purchase reported on Form 46,400$31.7K2026-07-29
2026-07-29P, purchase reported on Form 41,810$9.1K2026-07-29
2026-07-29P, purchase reported on Form 41,600$8.0K2026-07-29
2026-07-30P, purchase reported on Form 450,000$248.6K2026-08-03
2026-07-30P, purchase reported on Form 420,000$100.0K2026-08-03
2026-07-30P, purchase reported on Form 425,000$120.3K2026-08-03
2026-07-30P, purchase reported on Form 4100,000$490.0K2026-08-03
2026-07-30P, purchase reported on Form 477,850$385.8K2026-08-03
2026-07-31P, purchase reported on Form 43,300$16.4K2026-08-03
2026-07-31P, purchase reported on Form 425,000$124.5K2026-08-03
2026-07-31P, purchase reported on Form 48,003$38.4K2026-08-03

Rallybio Corp (RLYB)

10% owner · 2 filings · 7 purchases and sales
Trade dateCodeSharesValue as filedFiled
2026-05-11P, purchase reported on Form 425,000$350.0K2026-05-13
2026-05-11P, purchase reported on Form 45,100$71.4K2026-05-13
2026-05-11P, purchase reported on Form 419,900$278.6K2026-05-13
2026-05-12P, purchase reported on Form 4800$11.1K2026-05-13
2026-05-18P, purchase reported on Form 46,009$84.0K2026-05-20
2026-05-19P, purchase reported on Form 410,000$139.8K2026-05-20
2026-05-19P, purchase reported on Form 4200$2.8K2026-05-20

Keros Therapeutics, Inc. (KROS)

10% owner · 1 filing · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Palvella Therapeutics, INC. (PIRS)

10% owner · 1 filing · 3 purchases and sales
Trade dateCodeSharesValue as filedFiled
2024-08-09P, purchase reported on Form 43,000$44.7K2024-08-12
2024-08-12P, purchase reported on Form 4757$12.0K2024-08-12
2024-08-12P, purchase reported on Form 42,243$35.6K2024-08-12
Source

Counted from the Form 4 filings this reporting owner (SEC CIK 1940272) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-12 · For informational purposes only, not investment advice.
Privacy · Terms